
PFE · NYSE
Pfizer Inc.
$30.08 -0.29 (-0.95%)
Company overview
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers medicines and vaccines across several therapeutic areas, including cardiovascular, metabolic, and women's health treatments under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, along with oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NYSE
- Market cap
- $171B
- Employees
- 81,000
- Headquarters
- New York City, NY
- Website
- pfizer.com
- CEO
- Albert Bourla
- Listed
- June 1, 1972
- P/E
- 22.96
- Dividend yield
- 6.14%
Company financials
- Revenue
- $63.3B
- Gross profit
- $43.9B
- Operating income
- $14.8B
- EBITDA
- $16.9B
- Net income
- $7.5B
- EPS
- $1.31
- Total assets
- $208B
- Total debt
- $64.5B
- Gross margin
- 69.35%
- Net margin
- 11.83%
- Earnings yield
- 4.36%
Showing FY 2025